Seeking Alpha

Regenerative medicine firm hires its first CMO

  • Harvard Apparatus Regenerative Technology (HART -1.1%) hires Saverio La Francesca, M.D. as Chief Medical Officer.
  • Dr. Francesca joins the firm from the DeBakey Heart and Vascular Center in Houston. Prior to that he was an attending surgeon at the Department of Cardiopulmonary Transplantation at the Texas Heart Institute. He has direct experience in more than 1,000 organ transplants including 200+ heart and lung transplant procedures.
  • HART's lead product is a bioreactor/synthetic scaffold system for trachea transplants. Limited Phase 1 clinical trials have begun in Sweden and Russia.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector